Screener
Kura Oncology KURA Inventories
Inventories at other companies
Other financials
Where this comes from
Reported directly by Kura Oncology in its filing.
Tagged under the XBRL concept us-gaap:InventoryNet.
The source filing: Kura Oncology’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219481
| Line item | March 31, 2026 | December 31,2025 |
|---|---|---|
| Cash and cash equivalents | $39,083 | $149,099 |
| Short-term investments | 541,740 | 518,141 |
| Accounts receivable, net | 9,348 | 8,804 |
| Inventory | 843 | 413 |
| Prepaid expenses and other current assets | 32,768 | 32,206 |
| Total current assets | 623,782 | 708,663 |
| Property and equipment, net | 7,613 | 7,855 |
| Operating lease right-of-use assets | 7,166 | 7,302 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Kura Oncology's inventories?
- Kura Oncology (KURA) reported inventories of $843K in Q1 2026.
- How has Kura Oncology's inventories changed year-over-year?
- Kura Oncology's inventories increased by 716.5% year-over-year, from $103.25K to $843K.
- What does inventories mean?
- Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.
Ask your AI about Kura Oncology's inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude